Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | CJM112 |
| Trade Name | |
| Synonyms | CJM-112|CJM 112 |
| Drug Descriptions |
CJM112 is a human anti-Interleukin (IL)-17 antibody that inhibits IL-17 downstream signaling (ECTRIMS Oct 8, 2015, Abstract: P655). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C146808 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| CJM112 | CJM112 | 0 | 0 |
| CJM112 + Spartalizumab | CJM112 Spartalizumab | 0 | 2 |